Israel Englander Repligen Corp Put Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $179,685 - $251,025
1,500 Added 13.27%
12,800 $1.9 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $324,000 - $493,964
2,700 Added 31.4%
11,300 $1.42 Million
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $3.71 Million - $4.52 Million
-21,700 Reduced 71.62%
8,600 $1.58 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $3.46 Million - $5.62 Million
30,300 New
30,300 $5.45 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $320,840 - $512,419
-2,000 Reduced 40.0%
3,000 $561,000

Others Institutions Holding RGEN

# of Institutions
486
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email